Bio-Combination 5 (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the Bio-Combination 5 drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: FERRUM PHOSPHORICUM, KALI MURIATICUM, KALI SULPHURICUM, NATRUM MURIATICUM
SUBSTANCE NAME: FERROSOFERRIC PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM CHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00


Bio-Combination 5 HUMAN OTC DRUG Details:

Item DescriptionBio-Combination 5 from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 3; 3; 3([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2016-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-2360_99b8bea7-840d-4836-901c-220793f9d962
PRODUCT NDC: 15631-2360
APPLICATION NUMBER:

Other FERROSOFERRIC PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Rxhomeo Private Limited d.b.a. Rxhomeo, IncBio-Combination 5